A Phase I and Pharmacological Study with Imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a Novel Ruthenium Anticancer Agent

By J. Rademaker-Lakhai, D. H. van den Bongard, D. Pluim, Jos H. Beijnen, Jan H. M. Schellens. Clinical Cancer Research, 2004

704 citations recorded by the source corpus.

Subfields: Oncology, Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging

View Paper: https://www.semanticscholar.org/paper/d6b29d640d8b060a9dbbb0bc25ce435464ed3127